ArticleJournal of cellular and molecular medicine2017

HYDAMTIQ, a selective PARP-1 inhibitor, improves bleomycin-induced lung fibrosis by dampening the TGF-β/SMAD signalling pathway.

Laura Lucarini et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.